Safety Analysis of 10 Clinical Trials and for 13 Years After First Approval of Ioflupane 123I Injection (DaTscan)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Nuclear Medicine

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2967/jnumed.114.138032PMID 24947061
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MedDRA

  2020cited by this paper
• Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes

  2013cited by this paper
• EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease

  2013cited by this paper
• Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

  2013cited by this paper
• Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry

  2013cited by this paper
• Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies

  2013cited by this paper
• 123-I Ioflupane SPECT measures of Parkinson disease progression in the Parkinson Progression Marker Initiative (PPMI) trial

  2013cited by this paper
• EFNS task force: the use of neuroimaging in the diagnosis of dementia

  2012cited by this paper
• Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study

  2012cited by this paper
• European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis

  2012cited by this paper
• SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0*

  2012influential reference
• EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia

  2012cited by this paper
• Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects

  2012cited by this paper
• [123I]FP‐CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes

  2012cited by this paper
• Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study

  2012cited by this paper
• Thyroid protection before 123I-ioflupane (DaTSCAN) imaging

  2011cited by this paper
• Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I

  2010cited by this paper
• The role of DAT-SPECT in movement disorders

  2008cited by this paper
• Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs

  2008cited by this paper
• Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy

  2007cited by this paper
• Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.

  2007cited by this paper
• The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson’s disease

  2005cited by this paper
• Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

  2003cited by this paper
• [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease

  2003cited by this paper
• Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.

  2002cited by this paper
• [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.

  2001cited by this paper
• [Metabolism of 123I-FP-CIT in humans].

  1999cited by this paper
• Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

  1998cited by this paper
• Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters

  1997cited by this paper
• Characterization of C‐11 or I‐123 Labelled β‐CIT‐FP and β‐CIT‐FE Metabolism Measured in Monkey and Human Plasma. Identification of Two Labelled Metabolites with HPLC

  1996cited by this paper

• Monofluoromethylation of acyl chlorides and chloroformates employing fluorobis(phenylsulfonyl)methane. Synthesis of monofluoromethyl ketones via selective zinc-mediated reductive desulfonylation

  2025cites this paper
• Diagnosing Parkinson’s disease via behavioral biometrics of keystroke dynamics

  2025cites this paper
• Missed Insights for Earlier Management of Parkinson’s Disease and the Value of Dopamine Transporter (DAT) Scans

  2024influential citation
• Adverse reactions to radiopharmaceuticals.

  2021cites this paper
• Brain imaging using PET and SPECT

  2021cites this paper
• CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment

  2021cites this paper
• Tailor-Made Amino Acids and Fluorinated Motifs as Prominent Traits in the Modern Pharmaceuticals.

  2020cites this paper
• Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders

  2020cites this paper
• Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment

  2020cites this paper
• PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan

  2020cites this paper
• The role of molecular imaging in the frame of the revised dementia with Lewy body criteria

  2019cites this paper
• SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM)

  2019cites this paper
• Nuklearmedizinische Diagnostik bei Parkinson-Syndromen

  2019influential citation
• Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

  2019cites this paper
• Late onset depression: Association with clinical and imaging indicators of prodromal Parkinson’s disease

  2019cites this paper
• Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

  2018influential citation
• Diagnostic and prognostic aspects of clinical brain dopamine transporter imaging in parkinsonism

  2018cites this paper
• The utility of dopamine transporter scans for diagnosing Parkinsonian disorders

  2018cites this paper
• Neuroimaging in Lewy body dementia

  2018cites this paper
• Biomarkers in Parkinson disease: studies on clinical, radiological and biological biomarkers

  2018cites this paper
• Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework.

  2017cites this paper
• Restless legs syndrome, leg motor restlessness and their variants in patients with Parkinson's disease and related disorders.

  2017cites this paper
• Occipital lobe and posterior cingulate perfusion in the prediction of dementia with Lewy body pathology in a clinical sample

  2017cites this paper
• Identifying Subjects At Risk of Parkinson’s Disease in the Community: PREDICT-PD

  2016cites this paper
• Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT

  2016cites this paper
• Characterization of [123I]FP‐CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography

  2015cites this paper
• Overview of Dopamine Transporter Imaging in Parkinson’s Disease, Dementia with Lewy Bodies and Other Dementias

  2015cites this paper
• Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals.

  2015cites this paper
• Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors

  2015cites this paper